Swiss stocks - Factors to watch on March 23
23/03/2021 05:51
ZURICH/BERLIN, March 23 (Reuters) - The Swiss blue-chip SMI
.SSMI was seen opening 0.3% lower at 11,021 points on Tuesday,
according to premarket indications by bank Julius Baer
JBPRE01 .
Here are some of the main factors that may affect Swiss
stocks:
ROCHE ROG.S
New late-stage clinical trial data show an antibody cocktail
of casirivimab and imdevimab reduced hospitalisation or death by
70% versus a placebo in non-hospitalised patients with COVID-19,
the Swiss drugmaker said on Tuesday. urn:newsml:reuters.com:*:nFWN2LK0Z0
Roche is calling it quits on a late-stage trial of its
Huntington's disease hopeful tominersen, the drugmaker said on
Monday, a blow for sufferers of the rare, debilitating disease
with no treatments to stop or reverse it urn:newsml:reuters.com:*:nL8N2LK62A
CREDIT SUISSE CSGN.S
Alcimos Ltd said https://www.prnewswire.co.uk/news-releases/alcimos-potential-group-action-by-investors-in-credit-suisse-funds-affected-by-developments-at-greensill-capital-828174963.html
it had hired Swiss law firms Chabrier Avocats and Strelia to
advise it on potential claims against Credit Suisse over supply
chain finance funds linked to collapsed group Greensill that the
bank is winding down. "Advice received from Chabrier and Strelia
may be used for the purposes of organising and sourcing
litigation funding for a potential group action," it said
The Swiss bank has hired financial services investment
banker Chris Sanger from Evercore Inc. in New York to focus on
U.S. bank deals, Bloomberg reported.
Credit Suisse has been hit with additional European Union
antitrust charges, it said on Monday, three years after EU
enforcers charged the Swiss bank with rigging foreign exchange
rates in an almost decade-long case. urn:newsml:reuters.com:*:nL1N2LK1W5
NOVARTIS NOVN.S
Lu-PSMA-617 radioligand therapy helped improve survival for
patients with advanced castration-resistant prostate cancer in a
phase III study, the Swiss drugmaker said urn:newsml:reuters.com:*:nASN000ZCV
COMPANY STATEMENTS
* Zehnder Group AG ZEHN.S : will start a share buyback
programme corresponding to a maximum of 5% of the listed
registered shares A on March 24 urn:newsml:reuters.com:*:nFWN2LK10R
* Molecular Partners MOLN.S announced its intention to
conduct a registered offering in the United States. MOLN.S
* IGEA IGPH.S announced three new board members.
* Sunrise Communications SRCG.S said the commercial court
of Zurich had cancelled all publicly held registered shares of
the company. urn:newsml:reuters.com:*:nFWN2LK0JE
* Forbo Holding FORN.S launched a share buyback program
2019-2022 via a second trading line. urn:newsml:reuters.com:*:nFWN2LK0JC
* Orascom Development ODHN.S appointed Tarek Kamel as
chief executive of O West. urn:newsml:reuters.com:*:nFWN2LK0UM
* Wisekey WIHN.S said it was selected by Billon Group to
provide MPKI services. urn:newsml:reuters.com:*:nFWN2LK0J7
ECONOMY
No major economic data scheduled
(Reporting by Zurich newsroom and Berlin Speed Desk)
((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
((For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German .SDE
All SMI constituent stocks 0#.SSMI
DJ STOXX index .STOXX
Top 10 STOXX sectors .PGL.STOXXS
Top 10 EUROSTOXX sectors .PGL.STOXXES
Swiss mid-cap index .SSMI
Swiss all-share index .SSHI
Swiss market digest .AD.S
Sector overview CH/SECTOR1
All Swiss news CH
Swiss research news CH-RCH
All equity news E
SPEED GUIDES: EQUITY EQUITY/NEWS1 EUR/EQUITY SWITZERLAND REUTERS ))